Literature DB >> 17304721

[Polymorphisms in the genes of cytochrome oxidase P450 2D6 (CYP2D6), paraoxonase 1 (PON1) and apolipoprotein E (APOE) as risk factors for Parkinson's disease].

Gordana Durić1, Marina Svetel, Sergej Illarioskin Nikolaevic, Natasa Dragadević, Jelena Gavrilović, Vladimir S Kostić.   

Abstract

BACKGROUND/AIM: The presence of Parkinson's disease (PD) among the members of a family is a clear indication of the significance of genetics in its development. In spite of that, the majority of patients with PD shows a sporadic form of the disease induced as a result of interaction of both environmental and genetic factors. The aim of this study was to examine the effects of polymorphisms in the genes of cytohrome P450 2D6(CYP2D6), paraoxonase 1 (PON 1) and apolipoprotein E (APOE), as risk factors for PD.
METHODS: We examined 106 patients with PD (65 men and 41 women) and 75 ethnically matched control subjects. The mean age at onset of PD in the patients was 46.9+/-9.4 years (ranging from 30 to 70 years). Genotyping was performed using standard PCR amplification and restriction endonuclease digestion protocols described for known polymorphism in the candidate genes under study.
RESULTS: The genotype A/A polymorphisms 2D6* gene of CYP2D6 and genotype M/M polymorphisms L54M gene of PON1 were significantly more frequent in the patients with PD than in the control group. The patients with genotypes A/A and M/M had 3.4 and 3.2 higher risk of PD, respectively than the control group (p = 0.01). The relation between genotypes A/A gene of CYP2D6 and M/M gene of PON1 was modified by the age at onset. The genotypes were associated with early onset of PD (P = 0.001, p = 0.004). The carriers of the A and M alleles in homozygote had 2.4 and 4.2 years respectively earlier onset of PD than carriers of other genotypes with these polymorphisms. The frequency allele e4 gene of APOE was higher in the PD patients with early onset (20%) than in PD with later onset (7.4%), while the genotype epsilon3/epsilon3 was associated with PD late onset (p = 0.024). Combined genotype I (carriers of the two risk allels in homozygote and one alleles risk in heterozygote) and combined genotype II (carriers of the three alleles risk in homozygote) caused early PD. Combined genotype II was detected in 12.7% of the patients in the group of early onset, and in 2.4% of the patients with the onset after 45 years.
CONCLUSION: The results of our study suggest that the genotypes A/A and M/M genes of CYP2D6 and PON1, and allele epsilon4 gene are an important risk for the development of PD, causing its early onset. The cumulative effects of the risk genes cause an early onset of PD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17304721     DOI: 10.2298/vsp0701025d

Source DB:  PubMed          Journal:  Vojnosanit Pregl        ISSN: 0042-8450            Impact factor:   0.168


  8 in total

Review 1.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

Review 2.  Human PON1, a biomarker of risk of disease and exposure.

Authors:  C E Furlong; S M Suzuki; R C Stevens; J Marsillach; R J Richter; G P Jarvik; H Checkoway; A Samii; L G Costa; A Griffith; J W Roberts; D Yearout; C P Zabetian
Journal:  Chem Biol Interact       Date:  2010-03-23       Impact factor: 5.192

3.  Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study.

Authors:  Lisa F Potts; Alex C Cambon; Owen A Ross; Rosa Rademakers; Dennis W Dickson; Ryan J Uitti; Zbigniew K Wszolek; Shesh N Rai; Matthew J Farrer; David W Hein; Irene Litvan
Journal:  BMC Med Genet       Date:  2012-03-17       Impact factor: 2.103

Review 4.  Cytochrome P450 2D6 and Parkinson's Disease: Polymorphism, Metabolic Role, Risk and Protection.

Authors:  Mohd Sami Ur Rasheed; Abhishek Kumar Mishra; Mahendra Pratap Singh
Journal:  Neurochem Res       Date:  2017-09-04       Impact factor: 3.996

5.  Genome-wide autozygosity mapping in human populations.

Authors:  Shuang Wang; Chad Haynes; Francis Barany; Jurg Ott
Journal:  Genet Epidemiol       Date:  2009-02       Impact factor: 2.135

6.  Paraoxonase 1 polymorphisms are not related with the risk for multiple sclerosis.

Authors:  Carmen Martínez; Elena García-Martín; Julián Benito-León; Patricia Calleja; María Díaz-Sánchez; Diana Pisa; Hortensia Alonso-Navarro; Lucía Ayuso-Peralta; Dolores Torrecilla; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  Neuromolecular Med       Date:  2009-10-14       Impact factor: 3.843

7.  Association between serum paraoxonase 1 activity and its polymorphisms with multiple sclerosis: a systematic review.

Authors:  Nader Salari; Shna Rasoulpoor; Amin Hosseinian-Far; Nazanin Razazian; Kamran Mansouri; Masoud Mohammadi; Aliakbar Vaisi-Raygani; Rostam Jalali; Shervin Shabani
Journal:  Neurol Sci       Date:  2020-10-23       Impact factor: 3.307

8.  CYP2D6*4 allele polymorphism increases the risk of Parkinson's disease: evidence from meta-analysis.

Authors:  Yu Lu; Cuiju Mo; Zhiyu Zeng; Siyuan Chen; Yantong Xie; Qiliu Peng; Yu He; Yan Deng; Jian Wang; Li Xie; Jie Zeng; Shan Li; Xue Qin
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.